Cargando…
Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the diseas...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Encephalitis and Neuroinflammation Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295877/ https://www.ncbi.nlm.nih.gov/pubmed/37492492 http://dx.doi.org/10.47936/encephalitis.2020.00045 |
_version_ | 1785063525268324352 |
---|---|
author | Lee, Soon-Tae |
author_facet | Lee, Soon-Tae |
author_sort | Lee, Soon-Tae |
collection | PubMed |
description | N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the disease largely depend on supportive care to control intractable symptoms. However, no prospective or controlled trials have been conducted on immunotherapy or supportive care principles in the disease. Thus, this study discusses and shares experience and ideas for symptomatic care of NMDAR encephalitis. |
format | Online Article Text |
id | pubmed-10295877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Korean Encephalitis and Neuroinflammation Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-102958772023-07-25 Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis Lee, Soon-Tae Encephalitis Review Article N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with multiple symptoms including memory loss, seizure, psychosis, aphasia, altered mentality, dyskinesia, autonomic dysfunction, and central hypoventilation. While immunotherapy protocols are improving, morbidity and mortality in the disease largely depend on supportive care to control intractable symptoms. However, no prospective or controlled trials have been conducted on immunotherapy or supportive care principles in the disease. Thus, this study discusses and shares experience and ideas for symptomatic care of NMDAR encephalitis. Korean Encephalitis and Neuroinflammation Society 2021-01 2020-12-21 /pmc/articles/PMC10295877/ /pubmed/37492492 http://dx.doi.org/10.47936/encephalitis.2020.00045 Text en Copyright © 2021 Korean Encephalitis and Neuroinflammation Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Lee, Soon-Tae Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis |
title | Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis |
title_full | Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis |
title_fullStr | Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis |
title_full_unstemmed | Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis |
title_short | Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis |
title_sort | symptomatic treatments of n-methyl-d-aspartate receptor encephalitis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295877/ https://www.ncbi.nlm.nih.gov/pubmed/37492492 http://dx.doi.org/10.47936/encephalitis.2020.00045 |
work_keys_str_mv | AT leesoontae symptomatictreatmentsofnmethyldaspartatereceptorencephalitis |